H. Kinoshita

发表

Effect of Oily Vehicles on Absorption of Mepitiostane by the Lymphatic System in Rats

T. Ichihashi, H. Kinoshita, Y. Takagishi, 1992, The Journal of pharmacy and pharmacology.

Effect of Bile on Absorption of Mepitiostane by the Lymphatic System in Rats

T. Ichihashi, H. Kinoshita, Y. Takagishi, 1992, The Journal of pharmacy and pharmacology.

Comparative hepatic transport of desglycylated and cyclic metabolites of rilmazafone in rats: Analysis by multiple indicator dilution method

Y. Sugiyama, S. Miyauchi, H. Suzuki, 1993, Biopharmaceutics & drug disposition.

New method for the simultaneous estimation of intrinsic hepatic clearance and protein binding by matrix inhibition

Motohiro Kato, T. Tachibana, Y. Nabuchi, 2008, Biopharmaceutics & drug disposition.

Pharmacokinetics of Oseltamivir in Young and Very Elderly Subjects

C. Rayner, A. Urae, H. Kinoshita, 2006, The Annals of pharmacotherapy.

The role of carbohydrate moiety on the disposition of recombinant human granulocyte colony-stimulating factor (rG·CSF) (2): The role of sialic acid

Motohiro Kato, H. Kinoshita, Ken Okano, 1993 .

Studies on the trimethadione metabolism as a tool for the assessment of drug-metabolizing capacity using plasma and urine of rats pretreated with phenobarbital and 3-methylcholanthrene.

T. Yoshida, H. Kinoshita, E. Tanaka, 1982, Journal of pharmacobio-dynamics.

Determination of plasma trimethadione and its metabolite carbon tetrachloride-intoxicated rat liver: a useful tool for estimation of hepatic drug metabolizing capacity.

T. Yoshida, H. Kinoshita, E. Tanaka, 1981, Journal of pharmacobio-dynamics.

Effects of Renal Function on Pharmacokinetics of Recombinant Human Granulocyte Colony-Stimulating Factor in Lung Cancer Patients

S. Kohno, M. Fukuda, K. Terashi, 2001, Antimicrobial Agents and Chemotherapy.

Plasma protein binding and urinary excretion of R- and S-epimers of an arylmalonylamino 1-oxacephem. I: In humans.

T. Ichihashi, H. Kinoshita, H. Yamada, 1981, Journal of pharmaceutical sciences.

Metabolic fate of recombinant human granulocyte colony-stimulating factor (rG·CSF): Investigation of metabolites in the serum after intravenous administration of 125I-rG·CSF and nonlabeled-rG·CSF in rats

Motohiro Kato, N. Hayakawa, H. Kinoshita, 1993 .

Pharmacokinetic studies of trimethadione and its metabolite in rats with chemical-induced liver injury.

H. Kinoshita, E. Tanaka, E. Takabatake, 1981, Journal of pharmacobio-dynamics.

Determination of trimethadione and its metabolite by gas chromatography with flame-thermionic detection and its application to pharmacokinetic studies of the drug in carbon tetrachloride-treated rats.

T. Yoshida, H. Kinoshita, E. Tanaka, 1983, Journal of chromatography.

The role of carbohydrate moiety on the disposition of recombinant human granulocyte colony-stimulating factor (rG·CSF) (1): Using deglycosylated-rG·CSF and rG-CSF from E. coli

H. Kinoshita, Ken Okano, J. Amano, 1993 .

Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Recombinant Human Granulocyte Colony Stimulating Factor (Lenograstim) Administration

S. Higuchi, N Hayashi, H Kinoshita, 1999, Journal of clinical pharmacology.

Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production.

E. Yukawa, S. Higuchi, H. Kinoshita, 1998, British journal of clinical pharmacology.

Absorption and disposition of epithiosteroids in rats (1): Route of administration and plasma levels of epitiostanol.

T. Ichihashi, H. Kinoshita, H. Yamada, 1991, Xenobiotica; the fate of foreign compounds in biological systems.

Enzyme immunoassay for captopril.

H. Kinoshita, Y. Tohira, S. Tanaka, 1986, Journal of pharmaceutical sciences.

Estimation of rhG-CSF absorption kinetics after subcutaneous administration using a modified Wagner-Nelson method with a nonlinear elimination model.

E. Yukawa, S. Higuchi, S. Ohdo, 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

The relationship between hepatic microsomal biphenyl 2-hydroxylase, 4-hydroxylase and urinary glucaric acid excretion in the rat

T. Yoshida, H. Kinoshita, E. Tanaka, 1985, European Journal of Drug Metabolism and Pharmacokinetics.

Intrinsic Lymphatic Partition Rate of Mepitiostane, Epitiostanol, and Oleic Acid Absorbed from Rat Intestine

H. Yamada, T. Ichihashi, H. Kinoshita, 1991, Pharmaceutical Research.

Prediction of human blood‐to‐plasma drug concentration ratio

Tomohisa Saito, H. Kinoshita, M. Kato, 2010, Biopharmaceutics & drug disposition.

Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failure.

N. Holford, S. Iida, H. Kinoshita, 2008, British journal of clinical pharmacology.

Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction.

S. Tokura, N. Ohishi, H. Kinoshita, 1992, Arzneimittel-Forschung.

Absorption and disposition of epithiosteroids in rats (2): Avoidance of first-pass metabolism of mepitiostane by lymphatic absorption.

T. Ichihashi, H. Kinoshita, H. Yamada, 1991, Xenobiotica; the fate of foreign compounds in biological systems.

Relationship between trimethadione metabolism and hepatic drug-oxidizing enzyme activities in different animal species.

T. Yoshida, H. Kinoshita, E. Tanaka, 1983, Journal of pharmacobio-dynamics.

The pharmacokinetics of ceftriaxone based on population pharmacokinetics and the prediction of efficacy in Japanese adults

T. Kawanishi, M. Hayashi, S. Iida, 2009, European Journal of Drug Metabolism and Pharmacokinetics.

Preparation of iodine labeled recombinant human erythropoietin.

N. Ohishi, H. Kinoshita, A. Okazaki, 1991, Arzneimittel-Forschung.